MedPath
NMPA Approval

Mirabegron Sustained-release Tablets

国药准字H20253412

February 20, 2025

Drug Information

米拉贝隆缓释片

片剂

50mg

化学药品

February 20, 2025

Company Information

Applicant Company

连云港经济技术开发区长江路29号

Manufacturing Company

连云港经济技术开发区长江路29号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

米拉贝隆缓释片 - NMPA 批准文号 | MedPath